Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CAPABLE

Financiado

Cerrado

CAncer PAtients Better Life Experience

After the primary intervention, most of cancer patients are managed at home, facing long-term treatments or sequelae, making the disease comparable to a chronic condition. Despite their benefit, strong therapeutic regimens often... ver más

31/01/2024

UNIPV

6M€

Presupuesto del proyecto: 6M€

Líder del proyecto

UNIVERSITA DEGLI STUDI DI PAVIA No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 11 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2024-01-31

SC1-DTH-01-2019: Big data and Artificial Intelligenc...

I+D

Cerrada hace 5 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

11 Participantes

UNIPV

838.09K€ | Lider

Deontics

396.58K€ | Participante

BIOMERIS

569.13K€ | Participante

UPM

304.58K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

REBECCA REsearch on BrEast Cancer induced chronic conditions support... 5M€ Cerrado

QUALITOP Monitoring multidimensional aspects of QUAlity of Life after... 5M€ Cerrado

ASCAPE Artificial intelligence Supporting CAncer Patients across Eu... 5M€ Cerrado

CLARIFY Cancer Long Survivors Artificial Intelligence Follow Up 5M€ Cerrado

PERSIST Patients centered SurvivorShIp care plan after Cancer treatm... 5M€ Cerrado

WISDOM Well-being improvement through the Integration of healthcare... 10M€ Cerrado

Duración del proyecto: 51 meses Fecha Inicio: 2019-10-28
Fecha Fin: 2024-01-31

Líder del proyecto

UNIVERSITA DEGLI STUDI DI PAVIA No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 6M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto After the primary intervention, most of cancer patients are managed at home, facing long-term treatments or sequelae, making the disease comparable to a chronic condition. Despite their benefit, strong therapeutic regimens often cause toxicity, severely impairing quality of life. This may decrease adherence to treatment, thus compromising therapeutic efficacy. Also due to age-related multimorbidity, patients and their caregivers develop emotional, educational and social needs. CAPABLE will develop a cancer patient coaching system with the objective of facing these needs/issues. The time is right to fully exploit Artificial Intelligence (AI) and Big Data potentialities for cancer care and bring them to patients’ home. CAPABLE will rely on predictive models based on both retrospective and prospective data (clinical data, data from unobtrusive environmental and wearable sensors, data from social media and questionnaires). Models will be integrated with existing clinical practice guidelines and made available to oncologists. Thanks to the mobile coaching system for patients, CAPABLE will allow identifying unexpected needs, and providing patient-specific decision support. This feature, together with the chance of discovering unknown adverse effects of new treatments, makes CAPABLE more than a personalised tool for improving life quality, an advance for the whole research community. Our team includes complementary partners with experience in data- and knowledge-driven AI, data integration, telemedicine, decision support. In addition, the involved patients’ association gives a unique opportunity to access thousands of questionnaires on patients’ needs, which will inform the system design. The project addresses EU priorities such as shifting care from hospitals to home to face scarcity of healthcare resources, facilitating patients’ re-integration in the society and in the labour market, and ensuring all EU citizens to benefit from an effective, novel cancer care model.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores